US Broker Ratings

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genomic Revolution with a 9.40% Revenue Growth

Illumina, Inc. (NASDAQ: ILMN), a prominent player in the healthcare sector, is making waves in the diagnostics and research industry with its cutting-edge genomic analysis solutions. Headquartered in San Diego,..

BioMarin Pharmaceutical Inc. (BMRN): Investor Outlook with a Promising 60% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a stalwart in the biotechnology sector, is capturing investor attention with a compelling potential upside of 60.22%, according to the latest analyst ratings. As a..

Incyte Corporation (INCY): Investor Outlook with 11.8% Potential Upside Reveals Promising Growth in Biotech

In the ever-evolving landscape of biotechnology, Incyte Corporation (NASDAQ: INCY) stands out as a formidable player. Headquartered in Wilmington, Delaware, this biopharmaceutical powerhouse engages in the discovery, development, and commercialization..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a -36.49% Potential Downside Amidst Global Vaccine Innovation

As Moderna, Inc. (NASDAQ: MRNA) continues to make headlines with its groundbreaking work in messenger RNA (mRNA) medicines, investors are closely watching the company’s financial health and market positioning. With..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring Growth Potential with a 4.42% Upside

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, particularly within the Diagnostics & Research industry, presents an intriguing investment opportunity. With a robust market cap of..

Teleflex Incorporated (TFX) Stock Analysis: Navigating a 24.66% Potential Upside in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $5.26 billion, the company has carved..

Tenet Healthcare Corporation (THC) Stock Analysis: Assessing a Potential 10% Upside with Strong Buy Ratings

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the U.S. healthcare sector, operates a diverse array of medical facilities that include hospitals, ambulatory surgery centers, and urgent care centers...

RadNet, Inc. (RDNT) Stock Analysis: Exploring a Potential 35% Upside in the Diagnostics & Research Sector

RadNet, Inc. (NASDAQ: RDNT) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $5.5 billion, RadNet is a..

Sanofi (SNY) Stock Analysis: Promising 34.57% Upside Amid Robust Dividend Yield

Sanofi (SNY), a titan in the healthcare sector, is attracting investor attention with a potential upside of 34.57% and a noteworthy dividend yield of 6.06%. As a leading player in..

Encompass Health Corporation (EHC) Stock Analysis: Evaluating a 23.68% Upside Potential

Encompass Health Corporation (NYSE: EHC) stands as a robust player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $11.82 billion, this Birmingham,..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Unveiling a 28.41% Potential Upside in Biotech

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, is attracting attention from investors seeking substantial growth potential. The company, with a robust market capitalization of $8.31..

Merck & Company, Inc. (MRK) Stock Analysis: Evaluating Its 7.94% Potential Upside

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, continues to be a focal point for investors with its robust pharmaceutical and veterinary product lines. With a..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A Potential 23.85% Upside for Healthcare Investors

Investors with an eye on healthcare stocks should take a closer look at Smith & Nephew SNATS, Inc. (SNN), a formidable player in the medical devices industry. With a robust..

Grifols, S.A. (GRFS) Stock Analysis: Is a 48.63% Potential Upside Within Reach for This Healthcare Giant?

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector, is an intriguing stock for investors seeking exposure to the drug manufacturing industry. With a market capitalization of $4.98..

Biogen Inc. (BIIB) Stock Analysis: Assessing a 8.32% Potential Upside for Strategic Investors

Biogen Inc. (NASDAQ: BIIB) has been a stalwart in the healthcare sector, specifically in the realm of drug manufacturing. With a market capitalization of $32.49 billion, Biogen stands as a..

Fresenius Medical Care AG (FMS) Stock Analysis: Exploring the 5.41% Potential Upside in Healthcare

Fresenius Medical Care AG (FMS), a prominent player in the healthcare sector specializing in medical care facilities, is drawing investor interest as it navigates the complexities of the global dialysis..

HCA Healthcare, Inc. (HCA) Stock Analysis: 6.45% Potential Upside and Strong Buy Ratings

For investors eyeing the healthcare sector, HCA Healthcare, Inc. (NYSE: HCA) stands out as a significant player with its expansive network of medical care facilities. With a substantial market capitalization..

Repligen Corporation (RGEN)

⚠️ No article content returned.

..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating the Healthcare Tech Frontier with a $13.83 Billion Market Cap

Tempus AI, Inc. (NASDAQ: TEM) is making waves in the healthcare technology sector, focusing on integrating cutting-edge artificial intelligence with health information services. With a current market capitalization of $13.83..

Corcept Therapeutics (CORT) Stock Analysis: A 21% Upside Potential in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) stands out in the biotechnology sector with a compelling growth narrative, driven by its innovative treatments for severe endocrinologic, oncologic, metabolic, and neurologic disorders. Headquartered..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds